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Abstract Objective: To assess seminal oxidation–reduction potential (ORP) and
sperm DNA fragmentation (SDF) in male infertility and their relationships with
sperm morphology in fertile and infertile men.
Patients and methods: Prospective case-control study comparing the findings of
infertile men (n= 1168) to those of men with confirmed fertility (n= 100) regarding
demographics and semen characteristics (conventional and advanced semen tests).
Spearman rank correlation assessed the correlation between ORP, SDF, and differ-
ent morphological indices. Means of ORP and SDF were assessed in variable levels
of normal sperm morphology amongst all participants.
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ABBREVIATIONS
ART, assisted repro-
ductive techniques;
AUC, area under the
curve;
ICSI, intracytoplasmic
sperm injection;
IUI, intrauterine inse-
mination;
IVF, in vitro fertilisa-
tion;
NPV, negative predic-
tive value;
ORP, oxidation–
reduction potential;
OS, oxidative stress;
PPV, positive predic-
tive value;
ROC, receiver operat-
ing characteristic;
ROS, reactive oxygen
species;
SCD, sperm chromatin
dispersion
Results: Infertile patients had a significantly lower mean sperm count (32.7 vs 58.
7  106 sperm/mL), total motility (50.1% vs 60.4%), and normal morphology (5.7%
vs 9.9%). Conversely, infertile patients had significantly higher mean head defects
(54% vs 48%), and higher ORP and SDF values than fertile controls. ORP and
SDF showed significant positive correlations and significant negative correlations
with sperm head defects and normal morphology in infertile patients, respectively.
ORP and SDF were significantly inversely associated with the level of normal sperm
morphology. Using receiver operating characteristic curve analysis, ORP and SDF
threshold values of 1.73 mV/106 sperm/mL and 25.5%, respectively, were associated
with 76% and 56% sensitivity and 72% and 72.2% specificity, respectively, in differ-
entiating <4% from 4% normal morphology.
Conclusion: A direct inverse relationship exists between seminal ORP and SDF
with various levels of normal sperm morphology. Using ORP and SDF measures
in conjunction with standard semen morphology analysis could validate the result
of the fertility status of patients.
 2017 Production and hosting by Elsevier B.V. on behalf of Arab Association of
Urology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Infertility is the inability to conceive after at least 1 year of
regular unprotected intercourse. About 15% of couples
report thismedical problem [1].Globally, 30–50%of infer-
tility cases are due to a male factor, reaching up to 60%
where men are directly or partially responsible for the
infertility [2]. Clinicians rely on conventional semen
parameters for the initial evaluationofmale fertility poten-
tial, and spermmorphology assessment is one of its corner-
stones. Several approaches and classifications for sperm
morphology assessment have beenused including the strict
criteria of theWHOclassification, and themodifiedDavid
classification [3–5]. The most recent fifth edition of the
WHO manual recommends using strict criteria for exam-
ining spermmorphology, and provides a precise definition
of a normal spermatozoon [3]. Multiple abnormal sperm
morphology indices have been described in literature to
ease interpretation of this semen parameter, including
sperm deformity index (SDI), teratozoospermia index
(TZI), andmultiple abnormalities index (MAI). However,
data on their clinical relevance remain scarce [6,7].
Sperm morphology has been subject to considerable
debate about its ability to accurately predict in vivo and
in vitro conception. With the exception of some specific
sperm morphology defects, which are often linked to
genetic disorders (e.g. globozoospermia, macrocephaly,
decapitated sperm syndrome, and fibrous sheath dys-
plasia), sperm morphology assessment has been sug-
gested to have very poor sensitivity and specificity in
the diagnosis of infertility [7]. Earlier studies have shown
sperm morphology to be one of the most important
semen parameters capable of predicting natural concep-
tion, intrauterine insemination (IUI), in vitro fertilisation
(IVF), and intracytoplasmic sperm injection (ICSI) out-
comes [8,9]. Nonetheless, more recent studies failed to
confirm such propositions [10,11], where for instance,
men with <1% normal forms were able to conceive
without IVF, and even men with 0% normal forms had
similar successful pregnancy outcome [12]. Furthermore,
Hotaling et al. [11] investigated the impact of terato-
zoospermia (<5% normal forms) on assisted reproduc-
tive outcomes to report that isolated teratozoospermia
was not associated with decreased clinical pregnancy
rates in cases of IVF with or without ICSI. Hence, alter-
native methods such as natural conception or even IUI
seem possible prior to seeking immediate IVF treatment
in men with severe teratozoospermia. Such controversy
highlights the uncertainty of conventional semen param-
eters in predicting true male fertility potential, and trig-
gers the search for advanced tests of sperm function
that could help improve diagnostic accuracy.
Seminal oxidative stress (OS) and sperm DNA frag-
mentation (SDF) are two advanced sperm function tests
that are increasingly used in the evaluation of infertile
men. OS has recently been identified as a major mediator
in the various causes of male infertility [13]. High levels
of reactive oxygen species (ROS) are found in the semen
samples of 25–40% of infertile men [14]. Although small
physiological levels of ROS are essential for normal
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sperm functions such as sperm capacitation, acrosome
reaction, and fertilisation [15], elevated seminal ROS
induce a state of OS that can cause sperm dysfunction
through aggravating membrane lipid peroxidation,
sperm DNA damage, and abortive apoptosis [16]. These
consequences can affect sperm structural and functional
integrity thereby altering motility, morphology, count,
and viability [16]. Most importantly is the OS effect on
the integrity of sperm DNA, where OS provokes nucleo-
tide modifications, DNA strand breaks and chromatin
cross-linking that result in SDF [17].
An accurate measure of OS is the oxidation–reduction
potential (ORP), which provides an overview of the redox
system through assessment of the net balance between
oxidants and reductants in any given medium. Recently,
ORP in the semen has been easily and comprehensively
measured using the Male Infertility Oxidative System
(MiOXSYS; Aytu BioScience Inc., Englewood, CO
USA) that enables wider application of OS analysis in
clinical and research settings [20]. ORP results provided
by the MiOXSYS are standardised, reliable, and repro-
ducible compared to previously used ROS assays [20,21].
Higher levels of ORP and SDF are associated with
worse sperm quality and provide reliable information
synergising the predictive value of semen analysis during
male fertility evaluation [19,21]. Whilst ORP and SDF
have been previously correlated with different semen
parameters, their relationship with various levels and
types of sperm morphological anomalies has never been
investigated. The present study assessed whether there is
a significant correlation between sperm morphology on
the one hand, and measures of OS and SDF in seminal
plasma on the other. Given the aforementioned contro-
versy between sperm morphology and fertility potential,
studying the relationship between sperm morphology
and these two advanced sperm function tests is of major
importance, as this would help in better understanding
the true clinical implication of sperm morphology on
fecundity. Therefore, the specific objectives of the pre-
sent study were to: (i) compare conventional semen
parameters (semen volume, sperm concentration, motil-
ity, and normal morphology) and advanced sperm func-
tion tests (ORP and SDF) between infertile patients and
fertile controls; (ii) explore the correlation between
ORP, SDF, and different morphological abnormalities;
(iii) examine the ORP and SDF levels associated with
various degrees of normal sperm morphology; and (iv)
assess the ORP and SDF threshold values differentiat-
ing ‘normal’ from ‘abnormal’ sperm morphology.
Patients and methods
Study design, sample and procedures
This prospective study was conducted at the specialised
Male Fertility Unit of Hamad Medical Corporation in
Qatar, an academic tertiary medical centre. Over a per-
iod of 12 months (June 2016–June 2017), 3142 infertile
patients were evaluated. The study was approved by
the Medical Research Centre (Institutional Review
Board) at Hamad Medical Corporation in Qatar, and
all participants provided signed informed consents
before being enrolled.
Cases comprised all men with primary or secondary
infertility attending the male infertility clinic. The exclu-
sion criteria were as follows: azoospermia, use of antiox-
idant therapy (may bias the results of the study,
particularly the ORP result), present/past history of
pyospermia (leucocytospermia), presence of clinically
palpable varicocele, history of chemical/radiation expo-
sure based on patients’ occupation, and presence of a
female factor of infertility. All female partners were
evaluated by a fertility specialist whose assessment aided
in selection of cases. Moreover, patients receiving med-
ications such as ketotifen or NSAIDs or who had his-
tory of chronic disease (chronic lung diseases, chronic
renal failure or liver failure) were also excluded. Of the
initial 3142 patients, 1168 patients met the inclusion cri-
teria and constituted the infertile patient group (cases).
The control group consisted of 100 men with con-
firmed fertility (established a pregnancy in the previous
24 months) and was recruited through an advertisement
placed at the same tertiary medical centre. Controls were
selected only after we received a proof of pregnancy in
the previous 24 months (child’s birth certificate and med-
ical report from the spouse’s gynaecologist stating that
pregnancy was spontaneous). The same exclusion crite-
ria previously mentioned were applied to the controls.
Data collection
Infertile patients and fertile controls were evaluated.
Information on participants’ demographics, history of
present illness, relevant past medical, surgical and family
histories, results of the general and local genital clinical
examinations, and the laboratory findings of conven-
tional semen analysis, ORP and SDF were collected.
Semen analysis parameters
Each participant provided a semen sample after 2–7
days of sexual abstinence. Standard semen analysis
was performed consistent with the fifth edition of the
WHO manual [3], manually using a haemocytometer.
Sperm motility was assessed and categorised as progres-
sive or non-progressive. For sperm morphology assess-
ment, air-dried semen smears were fixed and stained
using the Diff-Quik kit (Baxter Healthcare Corporation,
Englewood, Chicago, IL, USA) by a single experienced
technician. The morphological abnormalities were
examined according to strict criteria, with the very low
normal sperm morphology threshold value of 4%
sORP and SDF with sperm morphology 89
[3]. A total of 5000 sperm were scored, and results were
expressed as percentage normal morphology. The per-
centage of abnormality in the sperm head, neck or tail
was recorded in each semen sample.
ORP
Consistent with others, ORP was measured in unpro-
cessed post-liquefied semen to assess test reproducibility
using the MiOXSYS [20]. The MiOXSYS comprises an
electrochemical analyser (Aytu BioScience, cat.
#100,229) and single-use disposable semen sensors (Aytu
BioScience; cat. # 100,283). As the analyser applies a
low-voltage steady current measured in millivolts (mV),
OS reflects the relationship between sperm (producers
of free radicals) and seminal plasma (an antioxidant
reservoir), thus raw ORP values (mV) were normalised
to sperm concentration, a value that reflects both semen
volume and sperm number. Data for ORP are presented
as mV/106 sperm/mL throughout [20].
SDF
SDF was evaluated in a subset of the study participants
(n= 365) using the sperm chromatin dispersion (SCD)
method or ‘Halosperm kit’ (Halotech DNA, SL,
Madrid, Spain) as per manufacturer’s instructions. The
method is based on the SCD assay test [21]. Unfixed
spermatozoa were immersed in an inert agarose micro-
gel on a pretreated slide. An initial acid treatment dena-
tures DNA in the spermatozoa with fragmented DNA.
The lysing solution removes most of the nuclear pro-
teins, and in the absence of large DNA breaks produces
nucleoids with large halos of spreading DNA loops,
emerging from a central core. Spermatozoa with frag-
mented DNA do not show dispersion halos or exhibit
very small halos. Both, positive and negative controls
were included. For positive control (sperm with halo),
the acid denaturation (0.08 M HCl) step was omitted.
For negative control (sperm without halo), after remov-
ing the coverslip, 10 mL undiluted denaturation solution
was applied and a cover slip was gently placed without
pressure and left for 5 min. A minimum of 500 sperma-
tozoa were scored and reported as percentage of sperm
with spermatozoa with fragmented DNA.
Statistical analyses
Analyses were performed using Statistical Package for
the Social Sciences software (SPSS version 24; SPSS
Inc., IBM Corp., Armonk, NY, USA), with significance
set at P< 0.05. Summaries of quantitative variables are
reported as mean ± standard error (SE) for the infertile
patients and fertile controls. Descriptive analysis
showed that the data were not normally distributed;
therefore the Mann–Whitney test was used to compare
means of age, count, motility, normal morphology,
abnormal morphological indices, SDF, and ORP
between infertile patients and fertile controls. Spearman
rank correlation examined the correlation (rs) between
ORP, SDF, sperm morphology, and the different mor-
phological indices for the fertile controls and the infer-
tile patients. Using the whole sample, we assessed the
mean ORP and SDF values associated with five increas-
ing levels of normal sperm morphology 0, 1, 2, 3 and
4%. A receiver operating characteristic (ROC) curve
was used to establish the threshold, sensitivity, speci-
ficity, area under the curve (AUC), accuracy, and the
ability for ORP and SDF to differentiate men with nor-
mal sperm morphology (4%) and abnormal sperm
morphology (<4%) [3].
Results
Characteristics of the sample
Table 1 describes the demographic, conventional semen
analysis, and advanced sperm function characteristics of
the infertile patients (n= 1168) and fertile controls
(n= 100). Infertile patients were significantly, 3 years,
older than fertile controls (P< 0.001). They had signif-
icantly lower mean conventional semen parameter val-
ues (lower sperm count, lower total motility, and
lower normal morphology). However, the mean mea-
sures of head defects, ORP and SDF values were signif-
icantly higher amongst the infertile patients than the
fertile controls (P< 0.001 for all; Table 1). The mean
ORP (mV/106 sperm/mL) in the semen of the infertile
patients was five-times higher than the fertile controls
(P< 0.001), and head defects were significantly higher
amongst infertile patients (54%) than fertile controls
(48%) (P< 0.001).
Table 1 Demographic, conventional semen analysis, and
advanced sperm function characteristics of the sample.
Variable, mean (SE) Infertile
patients
(n= 1169)
Fertile
controls
(n= 100)
P
Demography
Age, years 35.92 (0.22) 32.32 (0.72) <0.001
Abstinence, days 3.83 (0.05) 3.53 (0.13) 0.087
Conventional semen analysis
Volume, mL 3.17 (0.06) 2.73 (0.12) 0.067
Count, 106/mL 32.65 (0.78) 58.72 (2.5) <0.001
Total motility,% 50.07 (0.54) 60.41 (1.21) <0.001
Total morphology,% 5.72 (0.22) 9.86 (0.51) <0.001
Head defect,% 53.76 (0.43) 47.62 (0.67) <0.001
Neck defect,% 23.79 (0.25) 23.88 (0.59) 0.916
Tail defect,% 17.10 (0.24) 18.94 (0.71) 0.328
Advanced sperm function tests
SDF, % 27.60 (1.02) 15.68 (0.92) <0.001
ORP, mV/106 sperm/mL 5.44 (0.34) 1.18 (0.94) <0.001
Mann–Whitney test; bolded cells indicate statistical significance.
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Correlation between ORP, SDF and sperm morphology
parameters
Table 2 shows that amongst the fertile controls, there
was no correlation between ORP and SDF. The only
significant correlation was between SDF and sperm
head defects (rs = 0.36; P= 0.011; Fig. 1B). Both
the correlations between normal morphology and
ORP and SDF did not reach statistical significance
(P= 0.052 and 0.081, respectively).
Table 2 and Fig. 1A also show a significant correla-
tion between ORP and each of sperm head defects
(0.438) and normal morphology (rs = 0.56) amongst
the infertile patients. There were also significant correla-
tions between SDF and ORP (rs = 0.22; P< 0.001),
head defects (rs = 0.33; P< 0.001), and normal mor-
phology (rs = 0.35; P< 0.001). The correlation was
negative but not statistically significant for both ORP
and SDF with sperm neck (rs = 0.05, P= 0.06 and
rs = 0.23, P= 0.21) and sperm tail (rs = 0.09; P
= 0.11 and rs = 0.12; P= 0.39) defects, respectively.
Assessment of ORP and SDF in different levels of normal
sperm morphology
Table 3 depicts the mean ORP and SDF associated with
five increasing levels of normal morphology across the
whole sample. ORP was significantly inversely associ-
ated with the level of normal sperm morphology. Like-
wise, SDF was significantly inversely associated with
the level of normal sperm morphology. The ORP was
highest at 13.1 mV/106 sperm/mL in the 0% normal
sperm morphology group; and lowest for men with
4% normal sperm morphology at 1.99 mV/106
sperm/mL. Similarly, the mean SDF rate was highest
at 56% in the 0% normal sperm morphology group.
ROC curve analysis
ROC curves were generated both for ORP and SDF for
normal (4%) and abnormal (<4%) sperm morphol-
ogy (Fig. 2 A and B). ROC analysis suggested an
ORP threshold of 1.73 mV/106 sperm/mL in semen. At
this threshold, sensitivity was 76%, specificity 72%, pos-
itive predictive value (PPV) 69.2%, negative predictive
value (NPV) 78.6%, and accuracy 73.9% (AUC of
0.8; P< 0.001; Fig. 2A). Likewise, a SDF threshold of
25.5% had 56% sensitivity, 72.2% specificity, 60.4%
PPV, 69.4% NPV, and 65.9% accuracy (AUC of 0.69;
P< 0.001; Fig. 2B).
Discussion
The present study is the very first in the literature to
examine ORP and SDF levels at various intensities
and types of sperm morphological abnormalities. Both
ORP and SDF showed a significant inverse relationship
with levels of normal sperm morphology. Furthermore,
ORP and SDF had significant positive correlations with
sperm head defects, but not with neck or tail defects.
Our present infertile patients had significantly lower
conventional semen analysis parameters (sperm count,
total motility, and normal morphology) than fertile con-
trols, hence further validating the utility of semen anal-
ysis as a cornerstone for male fertility evaluation.
However, despite the ability of conventional semen anal-
ysis to assess sperm quality, it does not precisely and
accurately predict a man’s fertility [23] due to the many
factors, in addition to sperm and semen quality that
contribute to the ability of spermatozoa to fertilise an
oocyte. Of the different semen analysis parameters,
sperm morphology has been the most commonly inves-
tigated predictor of fertility, with remarkably contradic-
tory results, probably due to the subjective nature of
conventional sperm morphology testing, where many
issues arise concerning how sperm morphology should
be assessed, the test’s clinical relevance, and how to
interpret the thresholds of normal forms [23].
In male infertility, the choice between various assisted
reproductive techniques (ART), e.g. IUI, IVF or ICSI,
seems not very dependent on sperm morphology, as
there are no clear-cut recommendations, probably due
to the lack of rigorous randomised controlled trials,
the numerous biases inherent in most retrospective
Table 2 Correlations between ORP, SDF and sperm morphology amongst fertile controls and infertile patients.
ORP SDF, % Morphology, %
Abnormal Normal
Neck defect Head defect Tail defect
Infertile patients (n= 1169)
ORP 1 0.222** 0.051 0.438** 0.228 0.562**
SD, % 0.222** 1 0.092 0.327** 0.117 0.351**
Fertile controls (n= 100)
ORP 1 0.004 0.121 0.127 0.033 0.195
SDF, % 0.004 1 0.092 0.366* 0.190 0.257
ORP measured in mV/106 sperm/mL; *significant at 0.01 level; **significant at 0.001 level.
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Fig. 1 Significant correlations between ORP, SDF, and sperm morphology: (A) amongst infertile patients; (B) amongst fertile controls.
Table 3 ORP and SDF associated with five increasing levels of normal morphology across the whole sample (N= 1269).
Normal sperm forms morphology, mean (SE) P
0% 1% 2% 3% 4%
ORP 13.12 (1.84) 12.04 (1.27) 7.30 (0.73) 4.92 (0.55) 1.99 (0.26) <0.001
SDF,% 56.00 (8.18) 38.55 (3.75) 31.58 (2.71) 26.53 (2.16) 22.66 (1.04) <0.001
Mann–Whitney test; ORP measured in mV/106 sperm/mL.
Fig. 2 ROC curves for: (A) ORP threshold; (B) SDF threshold against <4% or 4% normal sperm morphology.
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studies, and the wide variations of thresholds and vari-
ety of classifications used by different researchers. For
instance, Van Waart et al. [8] compared IUI pregnancy
rates of men with 4 vs >4% normal sperm morphol-
ogy, where the meta-analysis revealed a risk difference
in pregnancy success between these two levels of normal
sperm morphology levels, and a significant improvement
in pregnancy rate for the >4% threshold using the strict
criteria. Others showed that the percentage of normal
sperm morphology was positively associated with suc-
cessful IVF (fertilisation rate and clinical pregnancy
rate) when the 5% (strict criteria) or the 14% (WHO
1999) thresholds were used [9]. However, these studies
did not examine isolated teratozoospermia, and impor-
tant male and female characteristics were also lacking
and hence not accounted for in the analyses. In contrast,
more recent studies failed to find a statistically signifi-
cant influence on ART outcomes between groups with
and without isolated teratozoospermia [5]. For example,
Hotaling et al. [11] examined, through four retrospective
studies, the relationship between severely isolated tera-
tozoospermia (<5% using the strict criteria) and clinical
pregnancy rate after conventional IVF or ICSI, to
report that teratozoospermia was not associated with
lower clinical pregnancy rates in IVF or ICSI. There-
fore, the predictive power of sperm morphology for
pregnancy outcomes in patients undergoing ART is
questioned [10,11].
For different sperm morphological anomalies, assess-
ment of the percentage of thin or amorphous head, or
bent or asymmetrical neck may be of limited clinical sig-
nificance, as their pathophysiologies remain not well
explained, as they are mostly physiological traits. How-
ever, some sperm morphology defects may be associated
with functional abnormalities e.g. chromatin condensa-
tion changes, acrosome reaction defects, tail motility
problems, or even increased apoptosis or necrosis
[26,27]. Our present results showed that sperm head
defects were significantly higher amongst infertile
patients compared with fertile controls, highlighting
the significance of the sperm head at the molecular
and genetic level. The sperm head encompasses nuclear
DNA, which is an integral element responsible for pack-
aging all paternal genetic information needed for the fer-
tilised egg’s early embryo development [28].
Such controversies in the predictive power of sperm
morphology exemplify some of the shortcomings that
still remain with conventional semen analysis testing,
paving the way for investigating the value of advanced
sperm function tests (ORP and SDF) for the evaluation
of infertile men. We demonstrated that ORP and SDF
were significantly higher amongst infertile patients com-
pared with fertile controls, and in order to assess the
association between sperm morphology and reproduc-
tive outcomes, we investigated, in-depth, the relation-
ship between ORP and SDF and this semen
parameter. OS is fundamental to male infertility patho-
physiology, as spermatozoa produce small amounts of
ROS during mitochondrial energy production, which
are generally counterbalanced by antioxidants in the
mitochondria and in seminal fluid [19]. The ROS antiox-
idants imbalance triggers OS, which may damage sperm
DNA and impair fertility [19].
ORP showed significant negative correlations with
normal sperm morphology and significant positive cor-
relations with sperm head defects amongst our present
infertile patients, where ORP significantly increased as
the normal sperm morphology levels decreased, reach-
ing 13.12 mV/106 sperm/mL at 0% normal sperm mor-
phology. Our present ROC curve analysis for ORP
threshold value that best differentiates <4% from
4% normal morphology depicted that an ORP thresh-
old of 1.73 mV/106 sperm/mL was associated with 76%
sensitivity, 72% specificity, 69.2% PPV, 78.6% NPV
and 73.9% accuracy. We used the MiOXSYS for ORP
measurement, which has been recently used for the eval-
uation of male infertility and its validity confirmed as an
accurate measure of OS in semen [29]. We are in agree-
ment with others, in that ORP was significantly higher
amongst infertile men compared with fertile controls
[29]. Whilst we found no published ROC curve analyses
performed for ORP against sperm morphology in order
to compare our present ROC findings with, nevertheless,
ORP threshold values between 1.36 and 2.59 mV/106
sperm/mL have been reported to differentiate fertile
from infertile men, or normal from abnormal semen
[20,22]. Our present sensitivity and specificity levels are
promising and suggest that ORP can be used as a valu-
able tool in estimating sperm morphology.
Using the SCD method, we found that SDF also
showed significant negative correlation with normal
sperm morphology, significant positive correlation with
sperm head defects, and SDF was significantly inversely
associated with normal sperm morphology levels, reach-
ing its highest level (56%) with the very low level (0%)
of normal sperm morphology. ROC curve analysis
examining the SDF threshold value that best differenti-
ates <4% from 4% normal morphology, depicted a
25.5% SDF threshold level to be associated with 56%
sensitivity, 72.2% specificity, 60.4% PPV, 69.4% NPV,
and 65.9% accuracy. There is increasing evidence on
the role of sperm DNA damage in infertility, and the
possible consequences of damaged sperm chromatin to
the offspring’s health [30]. Studies investigating SDF
thresholds using the SCD method have reported almost
identical values. For instance, recent research reported
80.8% sensitivity and 86.1% specificity when the
26.1% SDF threshold was used, with a 2.84 male infer-
tility prevalence ratio [31]. Along the same lines, the
SCD test had 86.2% sensitivity and 72.7% NPV (P=
0.02) in predicting successful ART treatment at 25.5%
threshold value [31,32]. Again, we are unable to directly
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compare our SDF ROC curve findings because previous
analyses [32] were performed to predict the likelihood of
fertility and were not intended for establishing a thresh-
old value that distinguishes normal from abnormal
sperm morphology.
Our present results highlight the importance of rou-
tinely incorporating advanced sperm function tests into
the evaluation of infertile men. The combination of
conventional sperm morphology indices with the
advanced sperm function tests would help recognise
sperm with greater reproductive potential despite
having abnormal morphology; and, provide robust
knowledge for developing novel sperm selection tech-
niques that can be used during ART. Our current
efforts to understand the clinical utility of sperm
DNA damage and ORP in relation to sperm morphol-
ogy in order to optimise reproductive outcomes seem
promising. Future research will be needed to test our
preliminary findings.
The present study has limitations. Only a subset
(28%) of our participants had undertaken SDF testing,
therefore, a smaller sample size (n= 365) for this partic-
ular test was used in the ROC curve analysis, which may
have contributed to the lower diagnostic accuracy
parameters in comparison with the ORP ROC curve
analysis, which displayed superior diagnostic accuracy.
However, SDF testing is still not routinely performed
for the initial evaluation of all of our infertile men,
and the more complex nature of the SDF test compared
to the simpler ORP test, hence both such features pre-
vented its utility for a larger group of our participants.
In addition, the present study provides a snapshot in
the lifetime of the infertile group, and follow-up of these
patients could more accurately assess the real implica-
tions of sperm morphology, SDF and ORP on repro-
ductive potential. Nevertheless, the present study is the
first to assess, in depth, the relationship between
advanced sperm function tests and sperm morphology
and provides solid grounds for future studies in this par-
ticular aspect of male infertility.
Conclusion
Infertile patients had significantly lower conventional
semen analysis parameters and significantly higher
ORP and SDF levels compared with fertile controls.
The infertile group showed significant negative correla-
tion and significant positive correlation between ORP
and SDF with normal sperm morphology and head
defects, respectively. ORP and SDF were significantly
associated with various intensities of normal sperm mor-
phology. An ORP and SDF levels of 1.73 mV/106
sperm/mL and 25.5%, respectively, had the highest
diagnostic accuracy in differentiating normal from
abnormal sperm morphology. Using ORP and SDF
measures in conjunction with standard semen morphology
analysis could be used to validate the result of the
fertility status of patients.
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